News | November 18, 2014

ASTRO Commends Medicare’s Decision to Cover Annual, Low-Dose CT Screenings

Screenings will benefit patients who have the highest risk of developing lung cancer

Lung cancer, ASTRO, CT Screen, National Lung Screening Trial

Image Courtesy of GE

November 18, 2014 — The American Society for Radiation Oncology (ASTRO) is supporting the Centers for Medicare and Medicaid Services' (CMS) decision to provide coverage for annual lung cancer screening via a low-dose CT screening for those at the highest-risk for lung cancer.  

The Proposed Decision Memo for Screening for Lung Cancer with Low Dose Computed Tomography (LDCT) (CAG-00439N) confirms that there is sufficient evidence to warrant annual lung cancer screening for patients most at risk for developing lung cancer.

The patient criteria for eligibility is as follows: aged 55 to 74; asymptomatic (no signs or symptoms of lung disease); a smoking history of at least 30 pack-years (one pack-year = smoking one pack per day for one year; 1 pack = 20 cigarettes); or a current smoker or someone who has quit smoking within the last 15 years.

Bruce G. Haffty, M.D., ASTRO chair, FASTRO remarks that lung cancer is the leading cause of cancer death for both men and women in the United States, with more than 160,000 people each year dying from the disease. This surpasses the number of deaths from breast, colon and prostate cancers combined. “With this annual screening in place, we will be able to diagnose patients earlier when treatment can be most successful, which will save thousands of lives,” Haffty says.

CMS’s decision follows the United States Preventive Task Force’s December 2013 recommendation that LDCT is a Grade B screening.

For more information: www.astro.org

Related Content

MedStar Georgetown Proton Center Selects RayStation for Treatment Planning
News | Treatment Planning | August 17, 2017
August 17, 2017 — The proton center at MedStar Georgetown University Hospital will utilize RayStation for planning on
Houston Methodist Hospital Enters Multi-Year Technology and Research Agreement With Siemens Healthineers
News | Imaging | August 17, 2017
Houston Methodist Hospital and Siemens Healthineers have entered into a multi-year agreement to bring cutting-edge...
DOSIsoft Releases ISOgray Proton Therapy Treatment Planning System
Technology | Treatment Planning | August 15, 2017
DOSIsoft SA announced the official release, with CE marking, of ISOgray Treatment Planning System (TPS) release 4.3 for...
First Radixact Results Presented at AAPM 2017
News | Radiation Therapy | August 10, 2017
Accuray Inc. announced that the first studies validating the benefits of the Radixact System were presented at the 59th...
Four Blue Cross Blue Shield Companies Issue Positive Medical Policies on HeartFlow FFRct Analysis
News | Computed Tomography (CT) | August 09, 2017
HeartFlow Inc. announced that four Blue Cross Blue Shield companies have each issued a positive medical policy for the...
Clinical Data Supports Use of Xoft System for Endometrial Cancer
News | Brachytherapy Systems | August 03, 2017
Researchers presented clinical data supporting use of the Xoft Axxent Electronic Brachytherapy (eBx) System for the...
Aktina’s interchangeable cones are lightweight and extremely accurate
News | Radiation Therapy | August 02, 2017
Aktina Medical announced a collaboration with Philips Medical Systems and Elekta Instruments for SRS interlocking at...
The American Lung Association created LUNG FORCE, a national movement to defeat lung cancer
News | Lung Cancer | August 02, 2017
To raise public awareness of lung cancer—the leading cancer killer of men and women—the American Lung Association's...
GE’s DoseWatch is a digital informatics solution that automatically collects, monitors and reports on radiation dose indices for diagnostic imaging exams
News | Radiation Dose Management | July 31, 2017
GE Healthcare announced that it has licensed computed tomography (CT) organ dosimetry technology developed at Duke...
Overlay Init